Table 3 Treatment related TEAEs.
System organ class Preferred term | Treatment | |
|---|---|---|
SB-121 (N = 15) n (%) | Placebo (N = 15) n (%) | |
Number of Subjects with at least one study treatment related TEAE | 3 (20.0) | 4 (26.7) |
Blood and lymphatic system disorders | 1 (6.7) | 0 |
Leukocytosis | 1 (6.7) | 0 |
Gastrointestinal disorders | 3 (20.0) | 4 (26.7) |
Diarrhea | 2 (13.3) | 3 (20.0) |
Abdominal pain | 0 | 1 (6.7) |
Abdominal pain upper | 1 (6.7) | 0 |
Vomiting | 0 | 1 (6.7) |
